BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18362835)

  • 1. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Uehara H; Nakaizumi A; Iishi H; Takenaka A; Eguchi H; Ohigashi H; Ishikawa O
    Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
    Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful pre-operative diagnosis of malignant intraductal papillary mucinous tumor of the pancreas by detecting telomerase activity.
    Murakami Y; Yokoyama T; Hiyama E; Yokoyama Y; Kanehiro T; Uemura K; Sasaki M; Morifuji M; Sueda T
    Int J Gastrointest Cancer; 2002; 31(1-3):117-21. PubMed ID: 12622422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
    Inoue H; Tsuchida A; Kawasaki Y; Fujimoto Y; Yamasaki S; Kajiyama G
    Cancer; 2001 Jan; 91(1):35-41. PubMed ID: 11148557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice].
    Suehara N; Mizumoto K; Niiyama H; Tanaka M
    Nihon Rinsho; 1998 May; 56(5):1223-8. PubMed ID: 9613127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.
    Suehara N; Mizumoto K; Kusumoto M; Niiyama H; Ogawa T; Yamaguchi K; Yokohata K; Tanaka M
    Am J Gastroenterol; 1998 Oct; 93(10):1967-71. PubMed ID: 9772067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Telomerase activity in pancreatic juice for the preoperative diagnosis of pancreatic cancer].
    Iwao T; Tsuchida A; Hiyama E; Kajiyama G
    Nihon Rinsho; 1998 May; 56(5):1229-33. PubMed ID: 9613128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
    Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
    Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in diagnosis of pancreatic cancer].
    Yamaguchi K; Ogawa Y; Yokohata K; Konomi H; Nakamura M; Nagata S; Tanaka M
    Gan To Kagaku Ryoho; 2005 May; 32(5):612-6. PubMed ID: 15918559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of telomerase activity of exfoliated cells in bile and its clinical impact].
    Yu SA; Peng CH; Wu RJ; Zheng ZD; Chen K; Fu ZN
    Ai Zheng; 2002 Feb; 21(2):177-80. PubMed ID: 12479071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.
    Nodari F; Baiocchi GL; Salvi A; De Petro G; Coniglio A; Ferrari Bravo A; Baronchelli C; Barlati S; Giulini SM
    Acta Biomed; 2003; 74 Suppl 2():59-64. PubMed ID: 15055037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
    Naritoku WY; Datar RH; Li P; Groshen SL; Taylor CR; Imam SA
    Cancer; 1999 Aug; 87(4):210-5. PubMed ID: 10455209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.